Last Updated on February 23, 2023
Key Points
The government of the Philippines updated its COVID-19 entrance requirements for travelers on 20 May 2022
Overview
As of 30 May 2022, the government of the Philippines will require fully vaccinated travelers to present proof of vaccination and a negative RT-PCR test taken 48 hours prior to departure.
Foreign nationals who cannot provide proof of vaccination will need to provide a proof of a negative RT-PCR test taken within 48 hours of departure or a rapid antigen test taken within 24 hours of departure. These travelers will also be required to undergo a facility-based quarantine for a period of five days. On the fifth day of quarantine, a negative RT-PCR test result must be produced. After the initial five-day quarantine, these individuals will need to undergo a home quarantine until 14 days have passed since they arrived in the Philippines.
What are the Changes?
The government of the Philippines updated its COVID-19 related entrance requirements on 20 May 2022. Travelers entering the country should ensure that they hold the appropriate travel authorization prior to arrival.
Looking Ahead
Continue to check the government of the Philippines website and Envoy’s website for the latest updates and information.
For more news and insights from around the world, please sign up for Envoy’s Global Blog Digest, emailed to you every Wednesday morning.
This article was published on 2 June 2022 and may not be the most recent update concerning COVID-19 entrance restrictions, testing requirements and quarantine measurers. For the most recent updates be sure to check our Global Mobility Resource Center.
Content in this publication is for informational purposes only and not intended as legal advice, nor should it be relied on as such. For additional information on the issues discussed, consult an attorney at one of the two U.S. Law Firms working with the Envoy Platform or another qualified professional. On non-U.S. immigration issues, consult an Envoy global immigration service provider or another qualified representative.